Finance

Lists
000963:SHE
Huadong Medicine Co., Ltd.
26,25 CN¥
-0,19%
(-0,050) 1D
16 հոկ, 15:04:24 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 000963...
Open
26,43 CN¥
High
26,90 CN¥
Low
25,98 CN¥
Mkt. cap
46,04 մլրդ
Avg. vol.
13,27 մլն
Volume
15,87 մլն
Dividend
3,54%
Quarterly dividend
0,23 CN¥
Ex-dividend date
18 սեպ, 2026 թ.
P/E ratio
13,27
52-wk high
43,78 CN¥
52-wk low
25,63 CN¥
EPS
1,98 CN¥
Shares outstanding
1,75 մլրդ
No. of employees
19 հզր
Open
26,43 CN¥
High
26,90 CN¥
Low
25,98 CN¥
Mkt. cap
46,04 մլրդ
Avg. vol.
13,27 մլն
Volume
15,87 մլն
Dividend
3,54%
Quarterly dividend
0,23 CN¥
Ex-dividend date
18 սեպ, 2026 թ.
P/E ratio
13,27
52-wk high
43,78 CN¥
52-wk low
25,63 CN¥
EPS
1,98 CN¥
Shares outstanding
1,75 մլրդ
No. of employees
19 հզր
News stories
From web sources and news partners
Profile
HD Medicine, or Huadong Medicine Co., Ltd., is a Hangzhou-based pharmaceutical company registered on the Shenzhen Stock Exchange since December 1999. It has a listed share capital of 380,000,000 RMB and a market capitalization of 5.1981 billion RMB as of June 2026. It is the largest pharmaceutical company in Zhejiang and the leading immunosuppressant manufacturer in China. In June 2025, the company received approval to commence clinical trials for Roflumilast Foam, targeting dermatological conditions. Wikipedia
About Huadong Medicine Co., Ltd.
CEO-
Employees19,1 հզր
Founded31 մրտ, 1993 թ.
Headquarters-
SectorHealth care provider
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
10,99 մլրդ
10,95 մլրդ
11,18 մլրդ
10,88 մլրդ
Cost of goods sold
7,39 մլրդ
7,79 մլրդ
7,39 մլրդ
7,45 մլրդ
Cost of revenue
7,39 մլրդ
7,79 մլրդ
7,39 մլրդ
7,45 մլրդ
Research and development expenses
507,92 մլն
245,56 մլն
350,37 մլն
396,72 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,93 մլրդ
1,99 մլրդ
2,19 մլրդ
1,92 մլրդ
Operating expense
2,33 մլրդ
2,51 մլրդ
2,60 մլրդ
2,41 մլրդ
Total operating expenses
9,72 մլրդ
10,31 մլրդ
9,99 մլրդ
9,86 մլրդ
Operating income
1,27 մլրդ
642,86 մլն
1,19 մլրդ
1,03 մլրդ
Other non operating income
-72,11 մլն
53,61 մլն
-4,09 մլն
-10,61 մլն
EBT including unusual items
1,07 մլրդ
753,84 մլն
1,19 մլրդ
1,02 մլրդ
EBT excluding unusual items
1,19 մլրդ
723,38 մլն
1,19 մլրդ
1,01 մլրդ
Income tax expense
130,93 մլն
84,85 մլն
195,03 մլն
176,07 մլն
Effective tax rate
12,24%
11,26%
16,36%
17,28%
Other operating expenses
-105,72 մլն
224,00 մլն
58,88 մլն
63,39 մլն
Net income
933,09 մլն
666,42 մլն
1,00 մլրդ
858,57 մլն
Net profit margin
8,49%
6,09%
8,96%
7,89%
Earnings per share
0,54
-
-
-
Interest and investment income
26,71 մլն
12,97 մլն
20,16 մլն
18,36 մլն
Interest expense
-33,70 մլն
-
-19,18 մլն
-12,03 մլն
Net interest expenses
-6,99 մլն
12,97 մլն
979,40 հզր
6,33 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
1,46 մլրդ
873,59 մլն
1,43 մլրդ
1,29 մլրդ
Gain or loss from assets sale
-6,20 մլն
-2,26 մլն
-
-1,42 մլն
AI content may include mistakes. Learn more
Google Apps